医療法人インテグレス 大宮エヴァグリーンクリニック
Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.
The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →
Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive
01C2507040 +4Location
- Prefecture
- Saitama
- Address
- さいたま市大宮区下町2丁目16-1 アクロスビル3F
Plan classification
- Class INot registered
- Class IIThe medium-risk category under the law.
- Class IIIThe low-risk category under the law.
Certified committee for regenerative medicine
- JSCSF再生医療等委員会
- ICTA特定認定再生医療等委員会
Public score
59.5/ 100
- A · Review level
- 25.0 / 30
- B · Technologies
- 20.6 / 35
- C · Coverage
- 7.1 / 25
- D · Class I / II technologies
- 6.7 / 10
The public score is calculated from public registration information and does not reflect quality of care. Scoring method →
Registered technologies (5)
Stem cells (all sources) 4
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 自己脂肪由来幹細胞を用いた慢性疼痛の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| 自己脂肪由来幹細胞を用いた糖尿病の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| 自己脂肪由来幹細胞を用いた慢性腎臓病の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| 自己脂肪由来幹細胞を用いたED(勃起不全)の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
Adipose-derived stem cells 4
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| 自己脂肪由来幹細胞を用いた慢性疼痛の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| 自己脂肪由来幹細胞を用いた糖尿病の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| 自己脂肪由来幹細胞を用いた慢性腎臓病の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
| 自己脂肪由来幹細胞を用いたED(勃起不全)の治療 | Stem cells (all sources)Adipose-derived stem cells | Class II |
NK and immune cells 1
| Registered technologies · Japanese original | Technology areas | Plan classification |
|---|---|---|
| ヒト自己活性化NK細胞による免疫細胞療法 | NK and immune cells | Class III |
Certified committee for regenerative medicine
- JSCSF再生医療等委員会
- ICTA特定認定再生医療等委員会
Public document number
01C250704001C260206101C250704101C251002103C2406024
Plan classification · Certified committee for regenerative medicine · Public document number
| Registered technologies | Plan classification | Certified committee for regenerative medicine | Public document number |
|---|---|---|---|
| 自己脂肪由来幹細胞を用いた慢性疼痛の治療 | Class II | JSCSF再生医療等委員会 | 01C2507040 |
| 自己脂肪由来幹細胞を用いた慢性腎臓病の治療 | Class II | JSCSF再生医療等委員会 | 01C2602061 |
| 自己脂肪由来幹細胞を用いたED(勃起不全)の治療 | Class II | JSCSF再生医療等委員会 | 01C2507041 |
| 自己脂肪由来幹細胞を用いた糖尿病の治療 | Class II | JSCSF再生医療等委員会 | 01C2510021 |
| ヒト自己活性化NK細胞による免疫細胞療法 | Class III | ICTA特定認定再生医療等委員会 | 03C2406024 |
Other institutions in the same prefecture
- 医療法人元気会 わかさクリニックPublic score 57.4
- 医療法人社団鴻愛会こうのす共生病院Public score 57.4
- UT整形外科 武蔵浦和Public score 56.2
- 医療法人社団 鴻愛会 with Life クリニック 大宮駅前Public score 56.2
- 医療法人社団nagomi会 健康スポーツクリニックPublic score 56.2
- 医療法人社団春陽会 大宮リビータ整形外科Public score 56.2
- 医療法人社団順生会 はにゅう整形外科Public score 56.2
- 大宮はしもと整形外科Public score 65.6